Compare NVAX & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | PGNY |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1996 | 2019 |
| Metric | NVAX | PGNY |
|---|---|---|
| Price | $8.05 | $37.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | $14.11 | ★ $37.25 |
| AVG Volume (30 Days) | ★ 5.8M | 972.3K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 309.76 | N/A |
| EPS | N/A | ★ 0.95 |
| Revenue | $1,123,479,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | N/A | $6.82 |
| Revenue Next Year | N/A | $11.43 |
| P/E Ratio | ★ N/A | $38.24 |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $6.20 | $16.10 |
| 52 Week High | $13.39 | $37.16 |
| Indicator | NVAX | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 34.94 | 83.18 |
| Support Level | $7.48 | $24.89 |
| Resistance Level | $10.64 | N/A |
| Average True Range (ATR) | 0.71 | 1.16 |
| MACD | -0.23 | 0.61 |
| Stochastic Oscillator | 1.09 | 99.53 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.